New cytogenetic abnormalities are frequent in AML and MDS relapsing after allogeneic hematopoietic cell transplantation (HCT).

被引：0
|
作者：
Pollyea, Daniel A.
Artz, Andrew S.
Stock, Wendy
Daugherty, Christopher
Godley, Lucy
Odenike, Olatoyosi M.
Rich, Elizabeth
Smith, Sonali M.
Zimmerman, Todd
Zhang, Yanming
Huo, Dezheng
Larson, Richard
Van Besien, Koen
机构：
[1] Cook Cty Hosp, Chicago, IL USA
[2] Univ Chicago Hosp, Chicago, IL 60637 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3675.3675
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3675
引用
收藏
页码：1050A / 1050A
页数：1
相关论文
共 50 条
  • [1] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
    El Chaer, Firas
    Borate, Uma
    Dulery, Remy
    Holtan, Shernan G.
    Law, Arjun Datt
    Muffly, Lori
    Nassereddine, Samah
    Shallis, Rory M.
    Stringaris, Kate
    Taylor, Justin
    Devine, Steven M.
    Mohty, Mohamad
    Hourigan, Christopher S.
    BLOOD ADVANCES, 2021, 5 (06) : 1757 - 1759
  • [3] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    B Oran
    S Giralt
    D Couriel
    C Hosing
    E J Shpall
    E de Meis
    I F Khouri
    M Qazilbash
    P Anderlini
    P Kebriaei
    U Popat
    A Carrasco-Yalan
    R E Champlin
    M de Lima
    Leukemia, 2007, 21 : 2540 - 2544
  • [4] Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation
    Oran, B.
    Giralt, S.
    Couriel, D.
    Hosing, C.
    Shpall, E. J.
    de Meis, E.
    Khouri, I. F.
    Qazilbash, M.
    Anderlini, P.
    Kebriaei, P.
    Popat, U.
    Carrasco-Yalan, A.
    Champlin, R. E.
    de Lima, M.
    LEUKEMIA, 2007, 21 (12) : 2540 - 2544
  • [5] Impact of the Novel 5-Group Cytogenetic Risk Classification of MDS on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)
    Deeg, H. Joachim
    Scott, Bart Lee
    Appelbaum, Frederick R.
    Gooley, Ted
    BLOOD, 2011, 118 (21) : 306 - 307
  • [6] Factors influencing relapse after allogeneic hematopoietic cell transplantation (HCT) following reduced intensity conditioning (RIC) in patients with AML and MDS
    Al-Ali, Haifa K.
    Nehring, Claudia
    Krahl, Rainer
    Becker, Cornelia
    Leiblein, Sabine
    Edelman, Jeanett
    Poenisch, Wolfram
    Lange, Thoralf
    Niederwieser, Dietger
    BLOOD, 2007, 110 (11) : 493A - 493A
  • [7] Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Heuser, Michael
    Koenecke, Christian
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Panagiota, Victoria
    Klesse, Sabrina
    Stadler, Michael
    Krauter, Juergen
    Dammann, Elke
    Wichmann, Martin
    Shahswar, Rabia
    Bhuju, Sabin
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kleine, Moritz
    Brauns, Wiebke
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Ganser, Arnold
    Kroeger, Nicolaus
    Thol, Felicitas
    BLOOD, 2015, 126 (23)
  • [8] IMMEDIATE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN ACUTE MYELOID LEUKEMIA (AML) ARISING FROM MYLEODYSPLASTIC SYNDROME (MDS)
    Choi, Y.
    Kim, S. -D.
    Park, Y. -H.
    Lee, J. S.
    Kim, D. -Y.
    Lee, J. -H.
    Lee, K. -H.
    Seol, M.
    Lee, Y. -S.
    Kang, Y. -A.
    Jeon, M.
    Jung, A. R.
    Lee, J. -H.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 25
  • [9] Immediate Allogeneic Hematopoietic Cell Transplantation (HCT) in Acute Myeloid Leukemia (AML) Arising From Myelodysplastic Syndrome (MDS)
    Kim, Sung-Doo
    Choi, Yunsuk
    Park, Young-Hun
    Lee, Jae Seok
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Jung, Ah Rang
    Lee, Je-Hwan
    BLOOD, 2011, 118 (21) : 888 - 889
  • [10] Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.
    Vaughn, Jennifer
    Storer, Barry
    Mielcarek, Marco
    Warren, Edus H., III
    Martin, Paul J.
    Sandmaier, Brenda M.
    Estey, Elihu H.
    Storb, Rainer
    Deeg, H. Joachim
    Scott, Bart Lee
    BLOOD, 2010, 116 (21) : 551 - 551
12345